Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC)

CUSIP: 359616109

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
67,171,444
Total 13F shares
51,666,381
Share change
-3,003,543
Total reported value
$242,831,448
Put/Call ratio
3.3%
Price per share
$4.70
Number of holders
117
Value change
-$8,308,464
Number of buys
51
Number of sells
72

Quarterly Holders Quick Answers

What is CUSIP 359616109?
CUSIP 359616109 identifies FULC - Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) as of Q4 2024

As of 31 Dec 2024, Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,666,381 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, BlackRock, Inc., Nantahala Capital Management, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and Woodline Partners LP. This page lists 117 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.